Document:

MabCure Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

Exhibit 10.1 

AMENDMENT TO 
SECURITIES PURCHASE AGREEMENT AND
DEBENTURE 

THIS AMENDMENT TO SECURITIES PURCHASE AGREEMENT (the
“Amendment”) is entered into as of the 2nd day of June, 2011, by
and between MabCure, Inc., a Nevada corporation, ("Company"), and
Centurion Private Equity, LLC, a Georgia Limited Liability Company
(“Buyer”). 

WHEREAS, the Company and the Buyer entered into a
Securities Purchase Agreement dated as of January 18, 2011 (the
“Agreement”); and 

WHEREAS, pursuant to the Agreement, the Buyer purchased
and the Company issued and sold in a private offering a $100,000 senior secured
convertible debenture (the “Debenture”) which was attached to the
Agreement as Exhibit A; and

WHEREAS, the Company and the Buyer wish to amend the
terms of the Agreement and the Debenture to fix the conversion price of the
Debenture in accordance with the terms and conditions set forth herein;

NOW, THEREFORE, the parties hereto hereby agree as
follows: 

	1. 	
      Definitions.

All capitalized terms used in this Amendment and not otherwise
defined herein shall have the meanings ascribed to such terms in the
Agreement.

	2. 	
      Conversion Price of the
  Debenture.

Section 3(b) of the Debenture is hereby deleted and replaced in
its entirety with the following amended sub-Section (b):

“(b) Conversion Price. The "Conversion Price"
shall equal $0.165 (subject to equitable adjustments for stock splits, stock
dividends or rights offerings by the Company relating to the Company's
securities or the securities of any Subsidiary of the Company, combinations,
recapitalization, reclassifications, extraordinary distributions and similar
events).” 

	3. 	
      Miscellaneous.

3.1          Each
of the parties hereto shall perform such further acts and execute such further
documents as may reasonably be necessary to carry out and give full effect to
the provisions of this Amendment and the intentions of the parties as reflected
thereby.

3.2         
Except as otherwise expressly limited herein, the provisions hereof shall inure
to the benefit of, and be binding upon, the successors, assigns, heirs,
executors, and administrators of the parties hereto.

3.3         
Except as specifically amended by this Amendment, the Agreement shall remain in
full force and effect. In the event of any inconsistency or conflict between the
Agreement and this Amendment, the terms and conditions of this Amendment shall
govern and control. This Amendment, along with the Agreement, constitute the
full and entire understanding and agreement between the parties with regard to
the subject matters hereof and thereof and supersede any prior agreement,
understanding, or contract, written or oral, with respect to the subject matter
hereof and thereof.

3.4          No
delay or omission to exercise any right, power, or remedy accruing to any party
upon any breach or default under this Amendment, shall be deemed a waiver of any
other breach or default theretofore or thereafter occurring. All remedies,
either under this Amendment or by law or otherwise afforded to any of the
parties, shall be cumulative and not alternative.

3.5          If
any provision of this Amendment is held by a court of competent jurisdiction to
be unenforceable under applicable law, then such provision shall be excluded
from this Amendment and the remainder of this Amendment shall be interpreted as
if such provision were so excluded and shall be enforceable in accordance with
its terms; provided, however, that in such event this Amendment shall be
interpreted so as to give effect, to the greatest extent consistent with and
permitted by applicable law, to the meaning and intention of the excluded
provision as determined by such court of competent jurisdiction. 

3.6          This
Amendment may be executed in counterparts, each of which when executed and
delivered shall be deemed to be an original, and all of which when taken
together shall constitute but one and the same instrument 

IN WITNESS WHEREOF, the parties hereto have caused this
Amendment to be executed by their duly authorized representatives. 

	The Company 	 	The Buyer 
	 	 	 	 
	 	 	 	 
	MabCure
      Inc.                                                	 	Centurion Private Equity,
      LLC                   
	 	 	 	 	 
	Name: 	/s/Amnon
      Gonenne              
      	 	Name: 	/s/Eric S.
      Swartz                  
      
	 	 	 	 	 
	Title: 	CEO                                  
             	 	Title: 	Manager                                
	 	 	 	 	 
	Date: 	June 6,
      2011                                 	 	Date: 	June 2,
      2011                                 

2MabCure Inc.: Exhibit 10.2 - Filed by newsfilecorp.com

Exhibit 10.2 

AMENDMENT
TO 
INVESTMENT
AGREEMENT 

THIS AMENDMENT TO INVESTMENT AGREEMENT (the “Amendment”)
is entered into as of the 2nd day of June, 2011, by and between
MabCure, Inc., a Nevada corporation, ("Company"), and Centurion
Private Equity, LLC, a Georgia Limited Liability Company
(“Investor”). 

WHEREAS, the Company and the Investor entered into an
Investment Agreement dated as of January 18, 2011 (the “Agreement”); and

WHEREAS, pursuant to the Agreement, the Company issued
to the Investor a certain number of Commitment Shares and Fee Shares; and

WHEREAS, the Company and the Investor wish to amend the
terms of the Agreement to increase the number of Commitment Shares by 465,224 in
accordance with the terms and conditions set forth herein;

NOW, THEREFORE, the parties hereto hereby agree as
follows: 

	1. 	
      Definitions.

All capitalized terms used in this Amendment and not otherwise
defined herein shall have the meanings ascribed to such terms in the
Agreement.

	2. 	
      Issuance of Additional Commitment
  Shares.

Not later than five (5) Business Days after the date of the
execution and delivery of this Amendment, in consideration for the Investor’s
execution and delivery of the Amendment to the Securities Purchase Agreement,
the Company shall issue to the Investor an additional 465,224 Commitment Shares.

	3. 	
      Miscellaneous.

3.1          Each
of the parties hereto shall perform such further acts and execute such further
documents as may reasonably be necessary to carry out and give full effect to
the provisions of this Amendment and the intentions of the parties as reflected
thereby.

3.2         
Except as otherwise expressly limited herein, the provisions hereof shall inure
to the benefit of, and be binding upon, the successors, assigns, heirs,
executors, and administrators of the parties hereto.

3.3         
Except as specifically amended by this Amendment, the Agreement shall remain in
full force and effect. In the event of any inconsistency or conflict between the
Agreement and this Amendment, the terms and conditions of this Amendment shall
govern and control. This Amendment, along with the Agreement, constitute the
full and entire understanding and agreement between the parties with regard to the subject
matters hereof and thereof and supersede any prior agreement, understanding, or
contract, written or oral, with respect to the subject matter hereof and
thereof.

3.4          No
delay or omission to exercise any right, power, or remedy accruing to any party
upon any breach or default under this Amendment, shall be deemed a waiver of any
other breach or default theretofore or thereafter occurring. All remedies,
either under this Amendment or by law or otherwise afforded to any of the
parties, shall be cumulative and not alternative.

3.5          If
any provision of this Amendment is held by a court of competent jurisdiction to
be unenforceable under applicable law, then such provision shall be excluded
from this Amendment and the remainder of this Amendment shall be interpreted as
if such provision were so excluded and shall be enforceable in accordance with
its terms; provided, however, that in such event this Amendment shall be
interpreted so as to give effect, to the greatest extent consistent with and
permitted by applicable law, to the meaning and intention of the excluded
provision as determined by such court of competent jurisdiction. 

3.6          This
Amendment may be executed in counterparts, each of which when executed and
delivered shall be deemed to be an original, and all of which when taken
together shall constitute but one and the same instrument 

IN WITNESS WHEREOF, the parties hereto have caused this
Amendment to be executed by their duly authorized representatives. 

	The Company 	 	The Investor 
	 	 	 	 
	 	 	 	 
	MabCure
      Inc.                                           	 	Centurion Private Equity,
      LLC              
	 	 	 	 	 
	Name: 	/s/Amnon
      Gonenne               	 	Name: 	/s/Eric S.
      Swartz                   
	 	 	 	 	 
	Title: 	CEO                                  
             	 	Title: 	Manager                                
	 	 	 	 	 
	Date: 	June 6,
      2011                            	 	Date: 	June 2,
      2011                            

2Caduceus Software Systems Corp.: Exhibit 10.1 - Filed by newsfilecorp.com

LICENSE AGREEMENT

THIS AGREEMENT dated for reference the 9th day of June,
2011.

AMONG:

SYGNIT CORPORATION., a
corporation with an office at 253 North Jackson Street, Frankfort, IN, USA,
46041

(herein called “Licensor”)

AND:

CADUCEUS SOFTWARE SYSTEMS CORP.
a corporation with an office at 42a High Street, Sutton Coldfield, West
Midlands, UK, B72 1UJ

(herein called “Licensee”)

AND:

ALEXANDER DANNIKOV, an
individual with an address at 26 Utkina Street, Suite 10, Irtkutsk, Russia,
664007

(herein called “Dannikov”)

WHEREAS:

A.          The
Licensor owns a suite of software named Caduceus MMS, for use in the medical
services industry. This software, along with all peripheries, libriaries,
modules as well as associated source code and object code is hereby referred to
as the “Software”. 

B.          The
Software is designated herein as constituting the Intellectual Property rights
concerned by the present license agreement. The know-how that the Licensor has
developed concerning the Software is not within the licensed Intellectual
Property rights (herein called the “IP Rights”).

C.          The
Licensee wishes to acquire from the Licensor and the Licensor agrees to grant to
the Licensee the exclusive right to use the IP Rights. 

E.          The
Licensor has agreed to grant the Licensee the exclusive right to use the IP
Rights under the terms and conditions as set forth in this License Agreement and
produce and distribute the Software on a worldwide basis. 

F.          In
order to induce the Licensor to enter into this License Agreement, Dannikov, a
director of the Licensee, has agreed to transfer to the Licensor 63,800,000
shares of the common stock of the Licensee held by Dannikov.

- 2 -

NOW THEREFORE in consideration of the premises and the
respective covenants, agreements representations, warranties and indemnities of
the parties herein contained and for other good and valuable consideration (the
receipt and sufficiency of which is hereby acknowledged) the parties hereto
covenant and agree as follows:

	1. 	
      DEFINED TERMS

	 	 	 
	1.1 	
      For the purposes of this Agreement, unless the context
      otherwise requires, the following terms will have the respective meanings
      set out below and grammatical variations of such terms will have
      corresponding meanings:

	 	 	 
		(a) 	
      “Business Day” means any day which is not a Saturday,
      Sunday or statutory holiday in the United Kingdom;

	 	 	 
		(b) 	
      “Closing” means the completion of the transactions
      contemplated in this Licence Agreement;

	 	 	 
		(c) 	
      “Closing Date” means such date as the Licensor and the
      Licensee may mutually determine;

	 	 	 
		(d) 	
      “IP Rights” has the meaning as ascribed in the whereas
      Clause B above.

	1.2 	
      Currency. Unless otherwise indicated, all dollar
      amounts in this License Agreement are expressed in United States
    funds.

	 	 
	1.3 	
      Sections and Headings. The division of this
      License Agreement into Articles, sections and subsections and the
      insertion of headings are for convenience of reference only and will not
      affect the interpretation of this License Agreement. Unless otherwise
      indicated, any reference in this License Agreement to an Article, section,
      subsection or Schedule refers to the specified Article, section or
      subsection of or Schedule to this License Agreement.

	 	 
	1.4 	
      Number, Gender and Persons. In this License
      Agreement, words importing the singular number only will include the
      plural and vice versa, words importing gender will include all genders and
      words importing persons will include individuals, corporations,
      partnerships, associations, trusts, unincorporated organizations,
      governmental bodies and other legal or business entities of any kind
      whatsoever.

	 	 
	1.5 	
      Accounting Principles. Except as otherwise stated,
      any reference in this License Agreement to generally accepted accounting
      principles refers to generally accepted accounting principles that have
      been established in the United States of America, including those approved
      from time to time by the American Institute of Certified Public
      Accountants or any successor body thereto.

	 	 
	1.6 	
      Entire Agreement. This License Agreement
      constitutes the entire agreement between the parties with respect to the
      subject matter hereof and supersedes all prior agreements, understandings,
      negotiations and discussions, whether written or oral. There are no
      conditions, covenants, agreements, representations, warranties or other
      provisions, express or implied, collateral, statutory or otherwise,
      relating to the subject matter hereof except as herein provided.

	 	 
	1.7 	
      Time of Essence. Time will be of the essence of
      this License Agreement.

- 3 -

	1.8 	
      Applicable Law. This License Agreement will be
      construed, interpreted and enforced in accordance with, and the respective
      rights and obligations of the parties will be governed by, the laws of
      England. All claim demands, disputes, controversies, differences, or
      misunderstandings between the Parties relating to this Agreement shall be
      settled by arbitration before one arbitrator to be appointed in accordance
      with the International Chamber of Commerce, such proceeding to be held in
      London in the English language and judgment upon the award rendered by the
      arbitrator may be entered in any court having jurisdiction
  thereof.

	 	 
	1.9 	
      Amendments and Waivers. No amendment or waiver of
      any provision of this License Agreement will be binding on either party
      unless consented to in writing by such party. No waiver of any provision
      of this License Agreement will constitute a waiver of any other provision,
      nor will any waiver constitute a continuing waiver unless otherwise
      provided.

	 	 
	1.10 	
      Adjustments for Stock Splits, Etc.. Wherever in
      this License Agreement there is a reference to a specific number of shares
      of stock of the Licensee, then, upon the occurrence of any subdivision,
      combination or stock dividend of such stock, the specific number of shares
      so referenced in this License Agreement shall automatically be
      proportionally adjusted to reflect the effect on the outstanding shares of
      such class or series of stock by such subdivision, combination or stock
      dividend.

	 	 
	2. 	
      GRANT OF LICENSE

	 	 
	2.1 	
      The Licensor hereby grants to the Licensee, effective as
      of the Closing Date and for a period of 5 years, an exclusive worldwide
      license to use the Software and IP Rights for a consideration of the
      License Fee defined in Article 5 hereafter (the “License”).

	 	 
	2.2 	
      The License Agreement will take effect on the day when
      the shares mentioned in Article 5 are issued and attributed to the
      Licensor.

	 	 
	2.3 	
      The Licensee agrees to assist the Licensor in recording
      this License Agreement with appropriate government authorities where such
      recording is required by law or regulation or where such recording is
      permitted or desired by the Licensor.

	 	 
	2.4 	
      The Licensor shall not continue to use the IP Rights for
      its business and shall not sell or agree to sell all or any portion of the
      IP Rights, other than as set out in Section 6.

	 	 
	2.5 	
      The Licensor undertakes, for a period of ten years from
      the signature of the License Agreement, to keep in force the existing
      trademark registrations in the countries where they were filed.

	 	 
	2.6 	
      If the Licensee receives financing of $200,000 or more
      within 6 months of the date of this Agreement the License shall extend
      perpetually.

	 	 
	3. 	
      USE OF LICENSE AND PURCHASE OF
    SOFTWARE

	 	 
	3.1 	
      The License is exclusive to the Licensee worldwide in
      which countries the Licensor has the exclusive right to produce and sell
      the Software direct;

- 4 -

	3.2 	
      The Licensee shall pursue the use of the Licensor's
      trademark on all the products produced by the Licensor and shall not use
      the Licensor's trademark or any trademark similar to "Caduceus MMS" for
      other products than the Licensor's products;

	 	 	 	 
	4. 	
      OWNERSHIP

	 	 	 	 
	4.1 	
      Licensee acknowledges and agrees that, as between the
      parties to this License Agreement and subject to the rights and licenses
      granted herein, Licensor is, and at all times shall remain, the sole and
      exclusive owner of all right, title and interest, throughout the world, in
      and to all IP Rights, and any copies of the IP Rights, whether made on or
      behalf of Licensor or Licensee.

	 	 	 	 
	5. 	
      LICENSE FEE

	 	 	 	 
	5.1 	
      The license fee payable by the Licensee to the Licensor
      for the License shall consist of 66,200,000 shares of restricted common of
      the Licensee (the “License Shares”). On or prior to the Closing Date, the
      Licensee and the Licensor shall enter into a subscription agreement in
      regards to the License Shares, as set forth in Exhibit A. On the Closing
      Date, the Licensee shall instruct its transfer agent to issue the License
      Shares to the Licensor. In any case, this Agreement shall take effect on
      the day of issuance of the License Shares and attribution of those Shares
      to the Licensor.

	 	 	 	 
	5.2 	
      In addition to the issuance of the License Shares,
      Dannikov shall transfer to the Licensor 63,800,000 shares of restricted
      common of the Licensee currently registered in his name.

	 	 	 	 
	6. 	
      RIGHT OF FIRST PURCHASE

	 	 	 	 
	6.1 	
      The Licensor shall give the Licensee a first right of
      purchase for the IP Rights, and the associated technology for so long as
      this License Agreement is in effect, in the event that:

	 	 	 	 
		(a) 	
      the Licensor, or a majority interest in the Licensor, is
      sold,

	 	 	 	 
		(b) 	
      the Licensor intends to sell the IP Rights, and the
      associated technology or

	 	 	 	 
		(c) 	
      the Licensor effects any:

	 	 	 	 
			(i) 	
      merger or consolidation of the Licensor with or into
      another entity,

	 	 	 	 
			(ii) 	
      sale of all or substantially all of its assets in one or
      a series of related transactions,

	 	 	 	 
			(iii) 	
      tender offer or exchange offer (whether by the Licensor
      or any or another entity) is completed pursuant to which the Licensor’s
      shareholders are permitted to tender or exchange their shares for other
      securities, cash or property,

	 	 	 	 
			(iv) 	
      reclassification of its shares or any compulsory share
      exchange pursuant to which the Licensor’s shares are effectively converted
      into or exchanged for other securities, cash or property, or

	 	 	 	 
		(d) 	
      the Licensee or the majority interest in the Licensee is
      being acquired by a company in which the present shareholders of the
      Licensee are not part of.

- 5 -

However, clauses (iii) and (iv) above
will only be applicable if the available shares pursuant to the tender offer or
exchange offer represent more than the majority of the shares of the Licensor.

(collectively, the “ROFP Events”).

	6.2 	
      The right of first purchase may be exercised by the
      Licensee within 30 days following notice of a ROFP Event by notifying the
      Licensor in writing. The purchase price of the IP Rights and the
      associated technology shall be calculated using the following formula: the
      purchase price of the IP Rights and the associated technology shall be
      equal to three (3) times the average annual sales turnover of the Software
      made by Licensee in the three years preceding the date of exercise of the
      right of purchase of the IP Rights.

	 	 	 	 
	7. 	
      TERMINATION AND EXTENSION

	 	 	 	 
	7.1 	
      Except as otherwise provided in Section 2.6, this License
      Agreement shall terminate automatically at the end of the term specified
      in Section 2.1.

	 	 	 	 
	7.2 	
      The Licence Agreement will be terminated if a bankruptcy
      proceeding is filed against the Licensee.

	 	 	 	 
	8. 	
      INDEMNIFICATION, REMEDIES,
  SURVIVAL

	 	 	 	 
	8.1 	
      For the purposes of this Section 8 terms “Loss”
      and “Losses” mean any and all demands, claims, actions or causes of
      action, assessments, losses, damages, liabilities, costs, and expenses,
      including without limitation, interest, penalties, fines and reasonable
      attorneys, accountants and other professional fees and expenses, but
      excluding any indirect, consequential or punitive damages suffered by
      Licensor or Licensee including damages for lost profits or lost business
      opportunities.

	 	 	 	 
	8.2 	
      Agreement of Licensor to Indemnify

	 	 	 	 
		(a) 	
      Licensor will indemnify, defend, and hold harmless, to
      the full extent of the law, for a period of three years from the
      termination of the License Agreement, the Licensee and its shareholders
      from, against, and in respect of any and all Losses asserted against,
      relating to, imposed upon, or incurred by the Licensee and its
      shareholders by reason of, resulting from, based upon or arising out
      of:

	 	 	 	 
			(i) 	
      the breach by Licensor of any representation or warranty
      of Licensor contained in or made pursuant to this License Agreement, any
      Licensor document or any certificate or other instrument delivered
      pursuant to this License Agreement; or

	 	 	 	 
			(ii) 	
      the breach or partial breach by Licensor of any covenant
      or agreement of Licensor made in or pursuant to this License Agreement,
      any Licensor document or any certificate or other instrument delivered
      pursuant to this License Agreement.

	 	 	 	 
	8.3 	
      Agreement of Licensee to Indemnify

	 	 	 	 
		(a) 	
      Licensee will indemnify, defend, and hold harmless, to
      the full extent of the law, for a period of three years from the
      termination of this License Agreement, the Licensor from, against, for,
      and in respect of any and all Losses asserted against, relating to,
      imposed upon, or incurred by Licensor by reason of, resulting from, based
      upon or arising out of:

- 6 -

	 	(i) 	
      the breach by Licensee of any representation or warranty
      of Licensee contained in or made pursuant to this License Agreement, any
      Licensee document or any certificate or other instrument delivered
      pursuant to this License Agreement; or

	 	 	 
	 	(ii) 	
      the breach or partial breach by Licensee of any covenant
      or agreement of Licensee made in or pursuant to this Agreement, any
      Licensee document or any certificate or other instrument delivered
      pursuant to this License Agreement.

	9. 	
      REPRESENTATIONS AND WARRANTIES OF THE
      LICENSOR

	 	 	 	 
	9.1 	
      The Licensor represents and warrants to the Licensee,
      with the intent that the Licensee will rely thereon in entering into this
      License Agreement and in concluding the transactions contemplated hereby,
      as follows:

	 	 	 	 
		(a) 	
      Licensor warrants that to the best of its knowledge the
      use of the IP Rights as intended through this License Agreement, does not
      infringe upon the rights of third parties;

	 	 	 	 
		(b) 	
      Licensor warrants that to the best of its knowledge the
      IP Rights is valid, maintained and enforceable towards third parties
      worldwide and that the IP Rights shall be properly maintained during the
      term of this License Agreement.

	 	 	 	 
		(c) 	
      the execution and delivery of this License Agreement and
      the completion of the transactions contemplated hereby have been duly and
      validly authorized by all necessary limited liability company action on
      the part of the Licensor, and this License Agreement constitutes a valid
      and binding obligation of the Licensor enforceable against the Licensor in
      accordance with its terms; except as enforcement may be limited by
      bankruptcy, insolvency and other laws affecting the rights of creditors
      generally and except that equitable remedies may be granted only in the
      discretion of a court of competent jurisdiction;

	 	 	 	 
		(d) 	
      neither the execution and delivery of this License
      Agreement nor the performance of the Licensor’s obligations hereunder
      will:

	 	 	 	 
			(i) 	
      violate or constitute default under any order, decree,
      judgment, statute, by-law, rule, regulation, or restriction applicable to
      the Licensor, the IP Rights, or any contract, agreement, instrument,
      covenant, mortgage, or security, to which the Licensor is a party or which
      are binding upon the Licensor,

	 	 	 	 
			(ii) 	
      to the knowledge of the Licensor, result in any fees,
      duties, taxes, assessments, penalties or other amounts becoming due or
      payable by the Licensee under any sales tax legislation.

	 	 	 	 
			(iii) 	
      give rise to the creation or imposition of any
      encumbrance on the IP Rights,

	 	 	 	 
			(iv) 	
      violate or constitute default under any license, permit,
      approval, consent or authorization held by the Licensor, or

	 	 	 	 
			(v) 	
      violate or trigger any liability on behalf of the
      Licensee pursuant to any legislation governing the licensing of the IP
      Rights by the Licensor;

- 7 -

	 	(e) 	
      the Licensor owns and possesses and has good and
      marketable title to the IP Rights free and clear of all encumbrances of
      every kind and nature whatsoever;

	 	 	 
	 	(f) 	
      no person other than the Licensee has any written or oral
      agreement or option or any right or privilege (whether by law, pre-emptive
      or contractual) capable of becoming an agreement or option for the
      purchase or acquisition from the Licensor of any of the IP
  Rights;

	 	 	 
	 	(g) 	
      There are no actions, suits, proceedings, investigations,
      complaints, orders, directives, or notices of defect or noncompliance by
      or before any court, governmental or domestic commission, department,
      board, tribunal, or authority, or administrative, licensing, or regulatory
      agency, body, or officer issued, pending, or to the best of the Licensor’s
      knowledge threatened against or affecting the Licensor or in respect of
      the IP Rights;

	 	 	 
	 	(h) 	
      there is no requirement applicable to the Licensor to
      make any filing with, give any notice to or to obtain any license, permit,
      certificate, registration, authorization, consent or approval of, any
      governmental or regulatory authority as a condition to the lawful
      consummation of the transactions contemplated by this Agreement, or that
      relate solely to the identity of the Licensee or the nature of any
      business carried on by the Licensee;

	10. 	
      REPRESENTATIONS OF THE LICENSEE

	 	 	 
	10.1 	
      The Licensee represents and warrants to the Licensor as
      follows, with the intent that the Licensor will rely thereon in entering
      into this License Agreement and in concluding the transactions
      contemplated hereby, that:

	 	 	 
		(a) 	
      the Licensee is a corporation duly incorporated, validly
      existing, and in good standing under the laws of the State of Nevada and
      has the power, authority, and capacity to enter into this License
      Agreement and to carry out its terms;

	 	 	 
		(b) 	
      the execution and delivery of this License Agreement and
      the completion of the transactions contemplated hereby has been duly and
      validly authorized by all necessary corporate action on the part of the
      Licensee, and this Agreement constitutes a valid and binding obligation of
      the Licensee enforceable against the Licensee in accordance with its
      terms; except as enforcement may be limited by bankruptcy, insolvency and
      other laws affecting the rights of creditors generally and except that
      equitable remedies may be granted only in the discretion of a court of
      competent jurisdiction;

	 	 	 
		(c) 	
      there is no requirement for the Licensee to make any
      filing with, give any notice to or obtain any license, permit,
      certificate, registration, authorization, consent or approval of, any
      government or regulatory authority as a condition to the lawful
      consummation of the transactions contemplated by this License
      Agreement;

	 	 	 
		(d) 	
      neither the execution and delivery of this License
      Agreement nor the performance of the Licensee’s obligations hereunder will
      violate or constitute a default under the constating documents, by-laws,
      or articles of the Licensee, any order, decree, judgment, statute, by-
      law, rule, regulation, or restriction applicable to the Licensee, or any
      contract, agreement, instrument, covenant, mortgage or security to which
      the Licensee is a party or which are binding upon the
  Licensee;

- 8 -

	 	(e) 	
      The License Shares to be issued to the Licensor under
      this Agreement will, when so issued, be duly authorized, validly issued,
      fully paid, non-assessable, free of any encumbrances and not subject to
      any preemptive rights or rights of first refusal created by statute or the
      charter documents or Bylaws of Licensee or any agreement to which Licensee
      is a party or is bound and will be issued in compliance with federal and
      state securities laws; and

	 	 	 
	 	(f) 	
      Except as disclosed in the Licensee SEC documents, (i)
      there are no actions, suits, proceedings, investigations, complaints,
      orders, directives, or notices of defect or non- compliance by or before
      any court, governmental or domestic commission, department, board,
      tribunal, or authority, or administrative, licensing, or regulatory
      agency, body, or officer issued, pending, or to the best of the Licensee’s
      knowledge threatened against or affecting the Licensee; and (ii) the
      Licensee is in compliance in all material respects with all applicable
      laws applicable to Licensee and its business.

	 	 	 
	 	(g) 	
      The Licensee will use its reasonable best efforts to
      ensure the commercial success of the Software during the life of this
      License Agreement.

	11. 	
      NON MERGER

	 	 
	11.1 	
      The representations, warranties, covenants, and
      agreements of the Licensor contained herein and those contained in the
      documents and instruments delivered pursuant hereto or in connection
      herewith will survive the Closing Date and the term of this License
      Agreement, and notwithstanding the completion of the transactions
      contemplated hereby, the waiver of any condition contained herein (unless
      such waiver expressly releases the Licensor of such representation,
      warranty, covenant, or agreement), or any investigation by the Licensee,
      same will remain in full force and effect.

	 	 
	11.2 	
      The representations, warranties, covenants, and
      agreements of the Licensee contained herein and those contained in the
      documents and instruments delivered pursuant hereto or in connection
      herewith will survive the Closing Date and the term of this License
      Agreement, and notwithstanding the completion of the transactions
      contemplated hereby, the waiver of any condition contained herein (unless
      such waiver expressly releases the Licensee of such representation,
      warranty, covenant, or agreement), or any investigation by the Licensor,
      same will remain in full force and effect.

	 	 
	12. 	
      FURTHER ASSURANCES

	 	 
	12.1 	
      From time to time subsequent to the Closing Date, the
      parties covenant and agree, at the expense of the requesting party, to
      promptly execute and deliver all such further documents and instruments
      and do all such further acts and things as may be required to carry out
      the full intent and meaning of this Agreement and to effect the
      transactions contemplated hereby.

	 	 
	13. 	
      ASSIGNMENT

	 	 
	13.1 	
      This Agreement may not be assigned by any party hereto
      without the prior written consent of the other parties
  hereto.

- 9 -

	14. 	
      SUCCESSORS AND ASSIGNS

	 	 
	14.1 	
      This Agreement will enure to the benefit of and be
      binding upon the parties hereto and their respective successors and
      permitted assigns.

	 	 
	15. 	
      COUNTERPARTS

	 	 
	15.1 	
      This Agreement may be executed in several counterparts,
      each of which will be deemed to be an original and all of which will
      together constitute one and the same instrument.

	 	 
	16. 	
      NOTICES

	 	 
	16.1 	
      Any notice required or permitted to be given under this
      Agreement will be in writing and may be given by personal service or by
      prepaid registered mail, and addressed to the proper party at such address
      as specified of the first page of this License Agreement. Any notice sent
      by registered mail as aforesaid will be deemed conclusively to have been
      effectively given on the fifth business day after posting; but if at the
      time of posting or between the time of posting and the third business day
      thereafter there is a strike, lockout or other labour disturbance
      affecting postal service, then such notice will not be effectively given
      until actually received. Any notice transmitted by electronic facsimile
      will be deem conclusively to have been effectively given if evidence of
      receipt is obtained before 5:00 p.m. (recipient’s time) on a Business Day,
      and otherwise on the Business Day next following the date evidence of
      receipt of transmission is obtained by the sender.

	 	 
	17. 	
      TENDER AND EXTENSIONS

	 	 
	17.1 	
      Tender may be made upon the Licensor or Licensee or upon
      the solicitors for the Licensor or Licensee and such solicitors are
      expressly authorized by their respective clients to confirm extensions of
      the Closing Date.

	 	 
	18. 	
      REFERENCE DATE

	 	 
	18.1 	
      This Agreement is dated for reference as of the date
      first above written, but will become binding as of the date of execution
      and delivery by all parties hereto and subject to compliance with the
      terms and conditions hereof, the transfer and possession of the Business
      Assets will be deemed to take effect as at the close of business on the
      Closing Date. References herein to the date of the Agreement or to the
      date hereof shall be deemed to mean the date set forth in the preamble to
      this Agreement.

- 10 -

IN WITNESS WHEREOF the parties have executed and delivered
these presents on the dates indicated below.

SYGNIT CORPORATION

	Per: 	/s/Christopher Donalds 	 
	  	President 	 

CADUCEUS SOFTWARE SYSTEMS CORP.

	Per: 	/s/Derrick Gidden 	 
	 	President  	 

ALEXANDER DANNIKOV

/s/Alexander Dannikov              

- 11 -

EXHIBIT A

Subscription
Agreement

CADUCEUS SOFTWARE SYSTEMS
CORP.

INSTRUCTIONS TO SUBSCRIBER:

	1. 	
      COMPLETE the information on page 2 of this
      Subscription Agreement.

	 	 
	2. 	
      COURIER the originally executed copy of the entire
      Subscription Agreement, together with the Questionnaire, to the Company
      at:

CADUCEUS SOFTWARE SYSTEMS CORP.

42a High
Street, Sutton Coldfield, West Midlands, UK, B72 1UJ

If you have any questions please contact Derrick Gidden,
President of the Company

- 12 -

SUBSCRIPTION AGREEMENT

	TO: 	Caduceus Software Systems Corp. (the “Company”)
    

Subject and pursuant to the attached “Terms and Conditions” of
this Subscription Agreement, including all schedules and appendices attached
hereto, the Subscriber hereby irrevocably subscribes for, and on the Closing
Date, will purchase from the Company, the following securities at the following
price:

	66,200,000
      Shares 
	The Subscriber owns, directly or
      indirectly, the following securities of the Company: 	 
	N/A 	 
	[Check if applicable]    The
      Subscriber is    [  ]    an affiliate of the Company 	 

The Subscriber directs the Company to issue, register and
deliver the certificates representing the Shares as follows:

	REGISTRATION INSTRUCTIONS 	 	DELIVERY
      INSTRUCTIONS 
	 	 	 
	Name to appear on certificate 	 	Name and account
      reference, if applicable 
	 	 	 
	Account reference if applicable 	 	Contact name 
	 	 	 
	Address 	 	Address 
	 	 	 
	Tax I.D./E.I.N./S.S.N. 	 	Telephone Number
  

EXECUTED by the Subscriber this 9th day of June, 2011.

	         
                         
                       
       WITNESS: 	 	EXECUTION BY
      SUBSCRIBER: 
	  	 	X 
	Signature of Witness 	 	Signature of
      individual (if Subscriber is an individual) 
	  	 	X 
	Name of Witness 	 	Authorized signatory
      (if Subscriber is not an individual) 
	 
	 	  
	Address of Witness 	 	Name of Subscriber
      (please print) 
	 
	 	  
	  	 	Name of authorized
      signatory (please print) 
	ACCEPTED and EFFECTIVE this 9th day of June, 2011		
	CADUCEUS SOFTWARE SYSTEMS CORP.
    	 	Address of
      Subscriber (residence) 
	per: 	 	  
	  	 	Telephone Number
  
	Authorized Signatory 	 	  
	  	 	E-mail address

	  	 	  
	  	 	Social
      Security/Insurance No.: 

By signing this acceptance, the Subscriber agrees to be bound
by the term and conditions of this Subscription Agreement.

NONE OF THE SECURITIES TO WHICH THIS PRIVATE PLACEMENT
SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”) RELATES HAVE BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933
ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE
OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS
(AS DEFINED HEREIN) EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE
ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

TERMS AND CONDITIONS

1.         
SUBSCRIPTION

1.1         The
undersigned (the "Subscriber") hereby irrevocably subscribes for and agrees to
purchase the number of shares of the Company's common stock (the "Shares") as
set out on page 2 of this Subscription Agreement pursuant to the terms of the
License Agreement (such subscription and agreement to purchase being the
"Subscription"), on the basis of the representations and warranties and subject
to the terms and conditions set forth herein.

1.2         The
Company hereby agrees to sell, on the basis of the representations and
warranties and subject to the terms and conditions set forth herein, to the
Subscriber the Shares. Subject to the terms hereof, the Subscription Agreement
will be effective upon its acceptance by the Company.

1.3         Unless
otherwise provided, all dollar amounts referred to in this Subscription
Agreement are in lawful money of the United States of America.

2.          
PAYMENT

2.1         Consuideration
for the issuance of the Shares shall be performance of the obligations in, and
the closing of, the License Agreement

3.          
QUESTIONNAIRES AND UNDERTAKING AND DIRECTION

3.1          The
Subscriber must complete, sign and return to the Company one (1) executed copy
of this Subscription Agreement; 

3.2          The
Subscriber shall complete, sign and return to the Company as soon as possible,
on request by the Company, any documents, questionnaires, notices and
undertakings as may be required by regulatory authorities, stock exchanges and
applicable law.

4.          
CLOSING

4.1          Closing
of the purchase and sale of the Shares shall be deemed to be effective on such
date as may be determined by the Company in its sole discretion (the "Closing
Date"). The Subscriber acknowledges that Shares may be issued to other
subscribers under this offering (the "Offering") before or after the Closing
Date. The Company, may, at its discretion, elect to close the Offering in one or
more closings, in which event the Company may agree with one or more subscribers
(including the Subscriber hereunder) to complete delivery of the Shares to such
subscriber(s) against payment therefore at any time on or prior to the Closing
Date.

5.          
ACKNOWLEDGEMENTS OF SUBSCRIBER

5.1          The
Subscriber acknowledges and agrees that:

	 	(a) 	
      none of the Shares have been registered under the 1933
      Act, or under any state securities or “blue sky” laws of any state of the
      United States, and, unless so registered, may not be offered or sold
    in the United States or to U.S. Persons,
as that term is defined in Regulation S under the 1933 Act (“Regulation S”),
except pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the 1933 Act;

	 	(b) 	
      the Subscriber acknowledges that the Company has not
      undertaken, and will have no obligation, to register any of the Shares
      under the 1933 Act;

	 	 	 
	 	(c) 	
      the decision to execute this Subscription Agreement and
      purchase the Shares agreed to be purchased hereunder has not been based
      upon any oral or written representation as to fact or otherwise made by or
      on behalf of the Company. If the Company has presented a business plan to
      the Subscriber, the Subscriber acknowledges that the business plan may not
      be achieved or be achievable;

	 	 	 
	 	(d) 	
      the Subscriber and the Subscriber’s advisor(s) have had a
      reasonable opportunity to ask questions of and receive answers from the
      Company in connection with the sale of the Shares hereunder, and to obtain
      additional information, to the extent possessed or obtainable without
      unreasonable effort or expense, necessary to verify the accuracy of the
      information about the Company;

	 	 	 
	 	(e) 	
      the decision to execute this Subscription Agreement and
      purchase the Shares agreed to be purchased hereunder has not been based
      upon any oral or written representation as to fact or otherwise made by or
      on behalf of the Company and such decision is based solely upon a review
      of publicly available information regarding the Company available on the
      website of the United States Securities and Exchange Commission (the
      "SEC") available at www.sec.gov (the "Company Information");

	 	 	 
	 	(f) 	
      the books and records of the Company were available upon
      reasonable notice for inspection, subject to certain confidentiality
      restrictions, by Subscribers during reasonable business hours at its
      principal place of business and that all documents, records and books in
      connection with the sale of the Shares hereunder have been made available
      for inspection by the Subscriber, the Subscriber’s attorney and/or
      advisor(s);

	 	 	 
	 	(g) 	
      by execution of this Subscription Agreement the
      Subscriber has waived the need for the Company to communicate its
      acceptance of the purchase of the Shares pursuant to this Subscription
      Agreement;

	 	 	 
	 	(h) 	
      all information which the Subscriber has provided to the
      Company in the Questionnaire is correct and complete as of the date the
      Questionnaire is signed, and if there should be any change in such
      information prior to the Subscription being accepted by the Company, the
      Subscriber will immediately provide the Company with such
    information;

	 	 	 
	 	(i) 	
      the Company is entitled to rely on the representations
      and warranties and the statements and answers of the Subscriber contained
      in this Subscription Agreement and in the Questionnaire, and the
      Subscriber will hold harmless the Company from any loss or damage it may
      suffer as a result of the Subscriber’s failure to correctly complete this
      Subscription Agreement or the Questionnaire;

	 	 	 
	 	(j) 	
      it will indemnify and hold harmless the Company and,
      where applicable, its respective directors, officers, employees, agents,
      advisors and shareholders from and against any and all loss, liability,
      claim, damage and expense whatsoever (including, but not limited to, any
      and all fees, costs and expenses whatsoever reasonably incurred in
      investigating, preparing or defending against any claim, lawsuit,
      administrative proceeding or investigation whether commenced or
      threatened) arising out of or based upon any representation or warranty of
      the Subscriber contained herein or in any document furnished by the
      Subscriber to the Company in connection herewith being untrue in any
      material respect or any breach or failure by the Subscriber to comply with
      any covenant or agreement made by the Subscriber to the Company in
      connection therewith;

	 	(k) 	
      the issuance and sale of the Shares to the Subscriber
      will not be completed if it would be unlawful or if, in the discretion of
      the Company acting reasonably, it is not in the best interests of the
      Company;

	 	 	 
	 	(l) 	
      it has been advised to consult its own legal, tax and
      other advisors with respect to the merits and risks of an investment in
      the Shares and with respect to applicable resale restrictions and it is
      solely responsible (and the Company is not in any way responsible) for
      compliance with applicable resale restrictions;

	 	 	 
	 	(m) 	
      it is acquiring the Shares as principal for its own
      account, for investment purposes only, and not with a view to, or for,
      resale, distribution or fractionalization thereof, in whole or in part,
      and no other person has a direct or indirect beneficial interest in such
      Shares;

	 	 	 
	 	(n) 	
      the Subscriber is acquiring the Shares pursuant to an
      exemption from the registration and prospectus requirements of applicable
      securities legislation in all jurisdictions relevant to this Subscription,
      and, as a consequence, the Subscriber will not be entitled to use most of
      the civil remedies available under applicable securities legislation and
      the Subscriber will not receive information that would otherwise be
      required to be provided to the Subscriber pursuant to applicable
      securities legislation;

	 	 	 
	 	(o) 	
      the Subscriber has been advised that the business of the
      Company is in a start-up phase and acknowledges that there is no assurance
      that the Company will raise sufficient funds to adequately capitalize the
      business or that the business will be profitable in the future;

	 	 	 
	 	(p) 	
      no documents in connection with the sale of the Shares
      hereunder have been reviewed by the Securities and Exchange Commission or
      any state securities administrators;

	 	 	 
	 	(q) 	
      there is no government or other insurance covering any of
      the Shares; and

	 	 	 
	 	(r) 	
      this Subscription Agreement is not enforceable by the
      Subscriber unless it has been accepted by the
Company.

6.          
REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
SUBSCRIBER

6.1         
The Subscriber hereby represents and warrants to and covenants with the
Company (which representations, warranties and covenants shall survive the
Closing) that:

	 	(a) 	
      the Subscriber is resident in the jurisdiction set forth
      on page 2 underneath the Subscriber’s name and signature;

	 	 	 
	 	(b) 	
      the Subscriber has the legal capacity and competence to
      enter into and execute this Subscription Agreement and to take all actions
      required pursuant hereto and, if the Subscriber is a corporation, it is
      duly incorporated and validly subsisting under the laws of its
      jurisdiction of incorporation and all necessary approvals by its
      directors, shareholders and others have been obtained to authorize
      execution and performance of this Subscription Agreement on behalf of the
      Subscriber;

	 	 	 
	 	(c) 	
      the Subscriber (i) has adequate net worth and means of
      providing for its current financial needs and possible personal
      contingencies, (ii) has no need for liquidity in this investment, and
      (iii) is able to bear the economic risks of an investment in the Shares
      for an indefinite period of time;

	 	 	 
	 	(d) 	
      the Subscriber has made an independent examination and
      investigation of an investment in the Shares and the Company and has
      depended on the advice of its legal and financial advisors and agrees that
      the Company will not be responsible in anyway whatsoever for the
      Subscriber’s decision to invest in the Shares and the
  Company;

	 	(e) 	
      the entering into of this Subscription Agreement and the
      transactions contemplated hereby do not result in the violation of any of
      the terms and provisions of any law applicable to, or the constating
      documents of, the Subscriber or of any agreement, written or oral, to
      which the Subscriber may be a  party or by which the Subscriber is or
      may be bound;

	 	 	 	 
	 	(f) 	
      the Subscriber has duly executed and delivered this
      Subscription Agreement and it constitutes a valid and binding agreement of
      the Subscriber enforceable against the Subscriber;

	 	 	 	 
	 	(g) 	
      it understands and agrees that none of the Shares have
      been registered under the 1933 Act or any state securities laws, and,
      unless so registered, none may be offered or sold in the United States or,
      directly or indirectly, to U.S. Persons (as defined herein) except
      pursuant to an exemption from, or in a transaction not subject to, the
      Registration Requirements of the 1933 Act and in each case only in
      accordance with state securities laws;

	 	 	 	 
	 	(h) 	
      it is purchasing the Shares for its own account for
      investment purposes only and not for the account of any other person and
      not for distribution, assignment or resale to others, and no other person
      has a direct or indirect beneficial interest is such Shares, and the
      Subscriber has not subdivided his interest in the Shares with any other
      person;

	 	 	 	 
	 	(i) 	
      it is able to fend for itself in the Subscription and has
      the ability to bear the economic risks of its prospective investment and
      can afford the complete loss of such investment;

	 	 	 	 
	 	(j) 	
      if it is acquiring the Shares as a fiduciary or agent for
      one or more investor accounts, it has sole investment discretion with
      respect to each such account and it has full power to make the foregoing
      acknowledgments, representations and agreements on behalf of such
      account;

	 	 	 	 
	 	(k) 	
      it understands and agrees that the Company and others
      will rely upon the truth and accuracy of the acknowledgments,
      representations and agreements contained in sections 5 and 6 hereof and
      agrees that if any of such acknowledgments, representations and agreements
      are no longer accurate or have been breached, it shall promptly notify the
      Company;

	 	 	 	 
	 	(l) 	
      the Subscriber:

	 	 	 	 
	 		(i) 	
      is knowledgeable of, or has been independently advised as
      to, the applicable securities laws of the securities regulators having
      application in the jurisdiction in which the Subscriber is resident (the
      “International Jurisdiction”) which would apply to the acquisition of the
      Shares,

	 	 	 	 
	 		(ii) 	
      is purchasing the Shares pursuant to exemptions from
      prospectus or equivalent requirements under applicable securities laws or,
      if such is not applicable, the Subscriber is permitted to purchase the
      Shares under the applicable securities laws of the securities regulators
      in the International Jurisdiction without the need to rely on any
      exemptions,

	 	 	 	 
	 		(iii) 	
      acknowledges that the applicable securities laws of the
      authorities in the International Jurisdiction do not require the Company
      to make any filings or seek any approvals of any kind whatsoever from any
      securities regulator of any kind whatsoever in the International
      Jurisdiction in connection with the issue and sale or resale of any of the
      Securities, and

	 	 	 	 
	 		(iv) 	
      represents and warrants that the acquisition of the
      Shares by the Subscriber does not trigger:

	 	 	 	 
	 			
      A. 
	any obligation to prepare and file a prospectus or
      similar document, or any other report with respect to such purchase in the
      International Jurisdiction, or

	 	B. 	
      any continuous disclosure reporting obligation of the
      Company in the International Jurisdiction, and

	 	(m) 	
      the Subscriber will, if requested by the Company, deliver
      to the Company a certificate or opinion of local counsel from the
      International Jurisdiction which will confirm the matters referred to in
      subparagraphs (ii), (iii) and (iv) above to the satisfaction of the
      Company, acting reasonably

	 	 	 	 
	 	(n) 	
      the Subscriber is not acquiring the Shares as a result of
      any form of general solicitation or general advertising including
      advertisements, articles, notices or other communications published in any
      newspaper, magazine or similar media or broadcast over radio, or
      television, or any seminar or meeting whose attendees have been invited by
      general solicitation or general advertising;

	 	 	 	 
	 	(o) 	
      no person has made to the Subscriber any written or oral
      representations:

	 	 	 	 
	 		(i) 	
      that any person will resell or repurchase any of the
      Shares;

	 	 	 	 
	 		(ii) 	
      that any person will refund the purchase price of any of
      the Shares;

	 	 	 	 
	 		(iii) 	
      as to the future price or value of any of the Shares;
      or

	 	 	 	 
	 		(iv) 	
      that any of the Shares will be listed and posted for
      trading on any stock exchange or automated dealer quotation system or that
      application has been made to list and post any of the Shares of the
      Company on any stock exchange or automated dealer quotation system, except
      that currently certain market makers make market in the shares of the
      Company's common stock on the OTC Bulletin Board.

6.2          In
this Subscription Agreement, the term “U.S. Person” shall have the meaning
ascribed thereto in Regulation S and for the purpose of the Subscription
includes any person in the United States.

7.          
ACKNOWLEDGEMENT AND WAIVER

7.1         The
Subscriber has acknowledged that the decision to purchase the Shares was solely
made on the basis of publicly available information. The Subscriber hereby
waives, to the fullest extent permitted by law, any rights of withdrawal,
rescission or compensation for damages to which the Subscriber might be entitled
in connection with the distribution of any of the Shares.

8.           REPRESENTATIONS
AND WARRANTIES WILL BE RELIED UPON BY THE COMPANY

8.1       
  The Subscriber acknowledges that the representations and
warranties contained herein are made by it with the intention that they may be
relied upon by the Company and its legal counsel in determining the Subscriber’s
eligibility to purchase the Shares under applicable securities legislation, or
(if applicable) the eligibility of others on whose behalf it is contracting
hereunder to purchase the Shares under applicable securities legislation. The
Subscriber further agrees that by accepting delivery of the certificates
representing the Shares on the Closing Date, it will be representing and
warranting that the representations and warranties contained herein are true and
correct as at the Closing Date with the same force and effect as if they had
been made by the Subscriber at the Closing Date and that they will survive the
purchase by the Subscriber of the Shares and will continue in full force and
effect notwithstanding any subsequent disposition by the Subscriber of such
Shares.

9.           RESALE
RESTRICTIONS

9.1          The
Subscriber acknowledges that any resale of the Shares will be subject to resale
restrictions contained in the securities legislation applicable to each
Subscriber or proposed transferee as set forth in paragraph 6 of this
Subscription Agreement. The Shares may not be offered or sold in the United
States unless registered in accordance with federal securities laws and all
applicable state securities laws or exemptions from such registration
requirements are available.

10.          
LEGENDING AND REGISTRATION OF SUBJECT SECURITIES

10.1          The
Subscriber hereby acknowledges that that upon the issuance thereof, and until
such time as the same is no longer required under the applicable securities laws
and regulations, the certificates representing any of the Shares will bear a
legend in substantially the following form:

	 	“NONE OF THE SECURITIES TO WHICH THIS
      PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”) RELATES
      HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED
      (THE “1933 ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED,
      NONE MAY BE OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO
      U.S. PERSONS (AS DEFINED HEREIN) EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A
      TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN
    EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.”
	 

10.2          The
Subscriber hereby acknowledges and agrees to the Company making a notation on
its records or giving instructions to the registrar and transfer agent of the
Company in order to implement the restrictions on transfer set forth and
described in this Subscription Agreement.

11.          
NOTICES TO RESIDENTS OF THE EUROPEAN ECONOMIC AREA

11.1          In
relation to each member state of the European Economic Area (the “EEA”) which
has implemented Directive 2003/71/EC (the “Prospectus Directive”) (each, a
“Relevant Member State”), Shares may only be offered or sold in the Relevant
Member State under the following exemptions under the Prospectus Directive, if
they have been implemented in that Relevant Member State:

	 	(a) 	
      to legal entities which are authorised or regulated to
      operate in the financial markets or, if not so authorised or regulated,
      whose corporate purpose is solely to invest in securities;

	 	 	 
	 	(b) 	
      to any legal entity which has two or more of (1) an
      average of at least 250 employees during the last financial year; (2) a
      total balance sheet of more than €43,000,000; and (3) an annual net
      turnover of more than €50,000,000, as shown in its last annual or
      consolidated accounts;

	 	 	 
	 	(c) 	
      in any other circumstances falling within Article 3(2) of
      the Prospectus Directive;

provided that no such offer of Shares shall result in a
requirement for the publication by the Company of a prospectus pursuant to
Article 3 of the Prospectus Directive.

12.          
COSTS

12.1          The
Subscriber acknowledges and agrees that all costs and expenses incurred by the
Subscriber (including any fees and disbursements of any special counsel retained
by the Subscriber) relating to the purchase of the Shares shall be borne by the
Subscriber.

13.          
GOVERNING LAW

13.1          This
Subscription Agreement is governed by the laws of the State of Nevada and the
federal laws applicable therein. The Subscriber, in its personal or corporate
capacity and, if applicable, on behalf of each beneficial purchaser for whom it
is acting, irrevocably attorns to the jurisdiction of the State of Nevada.

14.          SURVIVAL

14.1        This
Subscription Agreement, including without limitation the representations,
warranties and covenants contained herein, shall survive and continue in full
force and effect and be binding upon the parties hereto notwithstanding the
completion of the purchase of the Shares by the Subscriber pursuant hereto.

15.          ASSIGNMENT

15.1         This
Subscription Agreement is not transferable or assignable.

16.          EXECUTION

16.1         The
Company shall be entitled to rely on delivery by facsimile machine of an
executed copy of this Subscription Agreement and acceptance by the Company of
such facsimile copy shall be equally effective to create a valid and binding
agreement between the Subscriber and the Company in accordance with the terms
hereof.

17.          
SEVERABILITY

17.1          The
invalidity or unenforceability of any particular provision of this Subscription
Agreement shall not affect or limit the validity or enforceability of the
remaining provisions of this Subscription Agreement.

18.           
ENTIRE AGREEMENT

18.1          Except
as expressly provided in this Subscription Agreement and in the agreements,
instruments and other documents contemplated or provided for herein, this
Subscription Agreement contains the entire agreement between the parties with
respect to the sale of the Shares and there are no other terms, conditions,
representations or warranties, whether expressed, implied, oral or written, by
statute or common law, by the Company or by anyone else.

19.           
NOTICES

19.1          All
notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted by any standard form of
telecommunication. Notices to the Subscriber shall be directed to the address on
page 2 and notices to the Company shall be directed to it at the first page of
this Subscription Agreement.

20.          
COUNTERPARTS

20.1          This
Subscription Agreement may be executed in any number of counterparts, each of
which, when so executed and

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]